European Urology Focus
Издатель: Elsevier · ISSN 2405-4569 · 82 статей
- Flexible and Navigable Suction Ureteral Access Sheaths for the Treatment of Urolithiasis: Systematic Review and Meta-analysis
- Control of Confounding and Claims of Causality in Observational Studies of Neuraxial Anesthesia and Recurrence in Urologic Cancer: A Systematic Review
- Impact of Metastatic Hormone-sensitive Prostate Cancer Treatments on Health-related Quality of Life: A Systematic Review and Network Meta-analysis
- The Influence of Urinary Diversion Type on Body Image and Decision Regret Following Radical Cystectomy: A Systematic Review
- Kidney-sparing Treatments for Local Recurrence in Renal Cell Tumours After Partial Nephrectomy or Focal Therapy: A Systematic Review
- Consolidative Surgery for Advanced Upper Urinary Tract Urothelial Carcinoma After Enfortumab Vedotin and/or Immune Checkpoint Inhibitors
- From Crisis to Innovation: The Impact of COVID-19 on Outpatient Procedures in Robotic Urological Surgery
- Time-dependent Treatment Effects of Prostate-specific Membrane Antigen Radioligand Therapy in Metastatic Castration-resistant Prostate Cancer in the ENZA-p (ANZUP1901) Trial
- Re: Alexandra Masson-Lecomte, Guillaume Grisay, Julien Van Damme, et al. Challenges in Defining Clinical Complete Response to Systemic Therapy in Muscle-invasive Bladder Cancer: Insights from the EORTC STARBURST Project. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2025.03.005
- Re: Piet Ost, Shankar Siva, Sigmund Brabrabd, et al. Salvage Metastasis-directed Therapy Versus Elective Nodal Radiotherapy for Oligorecurrent Nodal Prostate Cancer Metastases (PEACE V–STORM): A Phase 2, Open-label, Randomised Controlled Trial. Lancet Oncol 2025;26:695–706
- Re: Guru P. Sonpavde. Role of Adjuvant Therapy in Current Perioperative Immunotherapy-based Trials in Bladder Cancer: A Justified Standard. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2025.05.008
- Re: Alec Zhu, Mary O. Strasser, Timothy D. McClure, et al. Comparative Effectiveness of Partial Gland Cryoablation Versus Robotic Radical Prostatectomy for Cancer Control. Eur Urol Focus 2024;10:843–50
- Re: Marie Semmler, Julian Marcon, Elena K. Berg, et al. Radical Prostatectomy Without Prior Biopsy? Final Histopathology of Radical Prostatectomies in 103 Consecutive Biopsy-naïve Patients Who Underwent Radical Prostatectomy. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2026.06.030
- Re: Benedikt Hoeh, Giovanni Mazzucato, Pierre Tennstedt, et al. Natural History of Patients Eligible for PROTEUS Diagnosed with Prostate Cancer and Treated with Radical Prostatectomy Without Perioperative Systemic Treatment. Eur Urol Focus. In press. http://dx.doi.org/10.1016/j.euf.2026.05.002
- How to Biopsy in Prostate Cancer Screening and Early Detection and Who Needs Antibiotics
- Reply to Flavio L. Heldwein et al’s Letter to the Editor re: Little M, Wolstenholme J, Landeiro F, Marian IR, Williams R, Francisco Lopez J, et al. Cost Effectiveness of Local Anaesthetic Transperineal Versus Transrectal Biopsy: Results from the TRANSLATE Study. Eur Urol Focus 2026;12:227–36
- First-in-clinical Evaluation of Dual Contrast-enhanced Ultrasound-guided PCNL: A Multicenter Randomized Trial Versus Fluoroscopy
- Editorial Board
- Contents
- Re: Carlsson SV, van den Bergh R. Prostate Cancer Screening: The Population Benefit Outweighs the Harm (Pro). Eur Urol Focus. 2026 Sep 16:S2405-4569(26)00197-5 doi:10.1016/j.euf.2026.09.001
- Clinical Predictors of Local and Atypical Site Recurrence After Partial and Radical Nephrectomy for Localized Renal Cell Cancer
- The Complex Relationship Between Volume and Outcome of AMS 800 Implants in the SATURN Database
- Radioligand Therapy of the Prostate – the Sky Is the Limit?
- PSMA Radioligand Therapy: Success and Limitations to Date
- Success and Limitations of PSMA RLT : The Nuclear Medicine View
- Lutetium-177-PSMA-617 in Oligo-metastatic Hormone-sensitive Prostate Cancer (BULLSEYE): A Trial Update
- ARALU - Phase 2, Open-label, Randomized Study to Investigate Safety and Efficacy of Pluvicto Therapy in Patients with Metastatic Hormone-sensitive Prostate Cancer in Addition to Standard of Care Treatment with Nubeqa and ADT
- Dose-intensified PSMA Radioligand Therapy: The Rationale Behind the OPTIMAL-PSMA Trial
- Practical Clinical Consultation Guide to Radioligand Therapy in Prostate Cancer
- Radioligand Therapy for Prostate Cancer – A Clinical Consultation Guide